FDA Approves Groundbreaking Sickle Cell Therapy Casgevy

FDA approves two groundbreaking new gene therapy treatments for sickle cell diseaseПодробнее

FDA approves two groundbreaking new gene therapy treatments for sickle cell disease

Biotechnology Weekly Update - December 14, 2023Подробнее

Biotechnology Weekly Update - December 14, 2023

Revolutionizing Sickle Cell Treatment: FDA Approves CRISPR Based Gene Therapies!Подробнее

Revolutionizing Sickle Cell Treatment: FDA Approves CRISPR Based Gene Therapies!

Doctor Reacts to Groundbreaking Sickle Cell TherapyПодробнее

Doctor Reacts to Groundbreaking Sickle Cell Therapy

New CRISPR-based sickle cell treatment, explainedПодробнее

New CRISPR-based sickle cell treatment, explained

FDA Approves First CRISPR Treatment in U.S.Подробнее

FDA Approves First CRISPR Treatment in U.S.

FDA approves groundbreaking sickle cell anemia treatmentПодробнее

FDA approves groundbreaking sickle cell anemia treatment